CAS 120041-08-9 Gadoteridol Related Compound A - Analytical Products / Alfa Chemistry

CAT	AP120041089
CAS	120041-08-9
Molecular Weight	404.46

Description	United States Pharmacopeia (USP) Reference Standard
Size	50MG

1

Generation of Multiparametric MRI Maps by Using Gd-labelled- RBCs Reveals Phenotypes and Stages of Murine Prostate Cancer

Giuseppe Ferrauto, Enza Di Gregorio, Stefania Lanzardo, Laura Ciolli, Manuela Iezzi, Silvio Aime

Sci Rep. 2018 Jul 12;8(1):10567.

PMID: 30002426

1

Magnetic Resonance Evaluation of Brain Metastases From Systemic Malignances With Two Doses of Gadobutrol 1.0 M Compared With Gadoteridol: A Multicenter, Phase ii/iii Study in Patients With Known or Suspected Brain Metastases

Nobuyuki Katakami, Yoshitaka Inaba, Shigenori Sugata, Masakatsu Tsurusaki, Takashi Itoh, Toru Machida, Hisashi Tanaka, Tetsuo Nakayama, Tsutomu Morikawa, Josy Breuer, Yasuko Aitoku

Invest Radiol. 2011 Jul;46(7):411-8.

PMID: 21467949

1

Multicenter Trial of Gadoteridol, a Nonionic Gadolinium Chelate, in Patients With Suspected Head and Neck Pathology

G H Zoarski, R B Lufkin, W G Bradley Jr, A E Flanders, D R Gale, S E Harms, V M Haughton, S E Joy, E Kanal, L Rosa

AJNR Am J Neuroradiol. Jul-Aug 1993;14(4):955-61.

PMID: 8352170

1

Phase II Clinical Trial of Gadoteridol Injection, a Low-Osmolal Magnetic Resonance Imaging Contrast Agent

M J Carvlin, D N De Simone, M J Meeks

Invest Radiol. 1992 Aug;27 Suppl 1:S16-21.

PMID: 1506148

* Products or Services Interested: Gadoteridol Related Compound A (120041-08-9)
* Your question
* Name
* Email
Verification Code